Nexair, LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 150 Stockton St, Jacksonville, Florida (FL) 32204, United States (USA)
- Operations here
- manufacture
- FDA identifiers
- FEI 1015040 · DUNS 969017086
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-07-11
- NAIDrug Quality Assurance2012-10-16
- NAIDrug Quality Assurance2010-05-03
Drugs this plant is listed as making
5 distinct drugs across 5 products name this site in their FDA label.
- AirNexAir, LLC
- Carbon DioxideNexAir, LLC
- NitrogenNexAir, LLC
- Nitrous OxideNexair, Llc
- OxygenNexAir, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.